CEACAM5 and non-small cell lung carcinoma: (26) developed a diagnostic panel consisting of SOX2OT, ANRIL, CEA, CYFRA21-1, and SCCA, which could be valuable in NSCLC diagnosis (sensitivity = 77.1%, specificity = 79.2%).